BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27258424)

  • 1. Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice.
    Hofrichter J; Krohn M; Schumacher T; Lange C; Feistel B; Walbroel B; Pahnke J
    J Alzheimers Dis; 2016 May; 53(3):967-80. PubMed ID: 27258424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
    Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
    J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500.
    Lo AC; Tesseur I; Scopes DI; Nerou E; Callaerts-Vegh Z; Vermaercke B; Treherne JM; De Strooper B; D'Hooge R
    Neuropharmacology; 2013 Dec; 75():458-66. PubMed ID: 24035915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
    J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
    Melnikova T; Fromholt S; Kim H; Lee D; Xu G; Price A; Moore BD; Golde TE; Felsenstein KM; Savonenko A; Borchelt DR
    J Neurosci; 2013 Feb; 33(9):3765-79. PubMed ID: 23447589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
    Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
    Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.
    Chen J; Zhang T; Jiao S; Zhou X; Zhong J; Wang Y; Liu J; Deng J; Wang S; Xu Z
    J Alzheimers Dis; 2017; 59(3):941-949. PubMed ID: 28697556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
    Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
    Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.
    Hofrichter J; Krohn M; Schumacher T; Lange C; Feistel B; Walbroel B; Heinze HJ; Crockett S; Sharbel TF; Pahnke J
    Curr Alzheimer Res; 2013 Dec; 10(10):1057-69. PubMed ID: 24156265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
    J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.